These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Restricting retrotransposons: ADAR1 is another guardian of the human genome. Orecchini E; Frassinelli L; Michienzi A RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy. Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338 [TBL] [Abstract][Full Text] [Related]
7. The role of RNA editing enzyme ADAR1 in human disease. Song B; Shiromoto Y; Minakuchi M; Nishikura K Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255 [TBL] [Abstract][Full Text] [Related]
8. Adenosine-to-inosine RNA editing in the immune system: friend or foe? Nakahama T; Kawahara Y Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954 [TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs. Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485 [TBL] [Abstract][Full Text] [Related]
10. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123 [TBL] [Abstract][Full Text] [Related]
11. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms. Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056 [TBL] [Abstract][Full Text] [Related]
12. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures. Fisher AJ; Beal PA RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139 [TBL] [Abstract][Full Text] [Related]
13. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325 [TBL] [Abstract][Full Text] [Related]
14. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer. Nakano M; Fukami T; Gotoh S; Nakajima M J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287 [TBL] [Abstract][Full Text] [Related]
15. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS. Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307 [TBL] [Abstract][Full Text] [Related]
16. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs. Heraud-Farlow JE; Walkley CR Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639 [TBL] [Abstract][Full Text] [Related]
17. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis. Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493 [TBL] [Abstract][Full Text] [Related]
18. Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1. Karki A; Campbell KB; Mozumder S; Fisher AJ; Beal PA Biochemistry; 2024 Feb; 63(3):282-293. PubMed ID: 38190734 [TBL] [Abstract][Full Text] [Related]
19. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2. Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133 [TBL] [Abstract][Full Text] [Related]
20. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]